Akura Medical (Series C)
Funding Details
Awarder
Inbox
Date Award
December 1, 2025
Vertical
Medical Technology
Funding Amount
$53,000,000
Company Info
Market
Venous Thromboembolism (VTE) Treatment
Location
Los Gatos, CA, USA
Coinvestors
Qatar Investment Authority
Company Description

Akura Medical is a medical technology company dedicated to addressing venous thromboembolism (VTE). Our flagship product, the Katana Thrombectomy System, is poised to redefine pulmonary embolism (PE) treatment standards by enabling removal of diverse clot types more efficiently.

Links